Literature DB >> 2008536

Antidepressant for substance-abusing schizophrenic patients: a minireview.

S G Siris1, P C Bermanzohn, S E Mason, M A Shuwall.   

Abstract

1. Substance abuse and post-psychotic depression are both frequently encountered concomitants of schizophrenia. 2. Substance abuse may be associated with depression-like symptomatology in the course of schizophrenia, and patients may attempt to self-medicate these symptoms with substances of abuse. 3. Antidepressant medication has been found to be a useful adjunct to treatment in at least some cases of substance abuse and some cases of post-psychotic depression. 4. Preliminary evidence exists suggesting that adjunctive antidepressant medication, added to a neuroleptic, may be useful for at least some stable dysphoric substance-abusing schizophrenic patients. 5. It is important to attempt to rule out even subtle neuroleptic-induced akinesia in such patients with a vigorous trial of antiparkinsonian medication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008536     DOI: 10.1016/0278-5846(91)90036-z

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

Review 1.  [Dual diagnosis of psychosis and addiction. From principles to practice].

Authors:  E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 2.  What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.

Authors:  Angelo G I Maremmani; Matteo Pacini; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-02-03       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.